RESUMEN
Members of the Rab family of small molecular weight GTPases regulate the fusion of transport intermediates to target membranes along the biosynthetic and endocytic pathways. We recently demonstrated that Rab1 recruitment of the tethering factor p115 into a cis-SNARE complex programs coat protein II vesicles budding from the endoplasmic reticulum (donor compartment) for fusion with the Golgi apparatus (acceptor compartment) (Allan BB, Moyer BD, Balch WE. Science 2000; 289: 444-448). However, the molecular mechanism(s) of Rab regulation of Golgi acceptor compartment function in endoplasmic reticulum to Golgi transport are unknown. Here, we demonstrate that the cis-Golgi tethering protein GM130, complexed with GRASP65 and other proteins, forms a novel Rab1 effector complex that interacts with activated Rab1-GTP in a p115-independent manner and is required for coat protein II vesicle targeting/fusion with the cis-Golgi. We propose a 'homing hypothesis' in which the same Rab interacts with distinct tethering factors at donor and acceptor membranes to program heterotypic membrane fusion events between transport intermediates and their target compartments.
Asunto(s)
Vesículas Cubiertas por Proteínas de Revestimiento/metabolismo , Aparato de Golgi/metabolismo , Proteínas de la Membrana/metabolismo , Proteínas de Saccharomyces cerevisiae , Proteínas de Transporte Vesicular , Proteínas de Unión al GTP rab1/metabolismo , Animales , Autoantígenos , Transporte Biológico Activo , Proteínas Portadoras/metabolismo , Proteínas Portadoras/fisiología , Línea Celular , Retículo Endoplásmico/metabolismo , Proteínas de la Matriz de Golgi , Inhibidores de Disociación de Guanina Nucleótido/metabolismo , Guanosina Trifosfato/metabolismo , Riñón , Hígado , Sustancias Macromoleculares , Fusión de Membrana , Proteínas de la Membrana/química , Proteínas de la Membrana/fisiología , Microscopía Fluorescente , Modelos Biológicos , Fosfoproteínas/metabolismo , Unión Proteica , Ratas , Especificidad por SustratoRESUMEN
A temperature-sensitive mutant of vesicular stomatitis G protein is used to follow the movement of that protein from the endoplasmic reticulum to transport vesicles to cis-Golgi and finally medial/trans-Golgi by assessing the maturation of two asparagine-linked oligosaccharides. These assays can be used to identify the factors that are required for and regulate protein trafficking through these compartments.
Asunto(s)
Asparagina/metabolismo , Retículo Endoplásmico/metabolismo , Aparato de Golgi/metabolismo , Glicoproteínas de Membrana/genética , Proteínas del Envoltorio Viral/genética , Factor 1 de Ribosilacion-ADP , Animales , Retículo Endoplásmico/virología , Glicosilación , Aparato de Golgi/virología , Glicoproteínas de Membrana/metabolismo , Oligosacáridos/metabolismo , Proteínas de Transporte Vesicular , Vesiculovirus/genética , Proteínas del Envoltorio Viral/metabolismoRESUMEN
The guanosine triphosphatase Rab1 regulates the transport of newly synthesized proteins from the endoplasmic reticulum to the Golgi apparatus through interaction with effector molecules, but the molecular mechanisms by which this occurs are unknown. Here, the tethering factor p115 was shown to be a Rab1 effector that binds directly to activated Rab1. Rab1 recruited p115 to coat protein complex II (COPII) vesicles during budding from the endoplasmic reticulum, where it interacted with a select set of COPII vesicle-associated SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) to form a cis-SNARE complex that promotes targeting to the Golgi apparatus. We propose that Rab1-regulated assembly of functional effector-SNARE complexes defines a conserved molecular mechanism to coordinate recognition between subcellular compartments.
Asunto(s)
Proteínas Portadoras/metabolismo , Retículo Endoplásmico/metabolismo , Aparato de Golgi/metabolismo , Glicoproteínas de Membrana , Proteínas de la Membrana/metabolismo , Fosfoproteínas/metabolismo , Proteínas de Saccharomyces cerevisiae , Proteínas de Transporte Vesicular , Proteínas de Unión al GTP rab1/metabolismo , Animales , Transporte Biológico , Proteínas de la Matriz de Golgi , Membranas Intracelulares/metabolismo , Fusión de Membrana , Mutación , Orgánulos/metabolismo , Ratas , Proteínas Recombinantes de Fusión/metabolismo , Proteínas SNARE , Proteínas del Envoltorio Viral/metabolismoRESUMEN
To analyze the role of coat protein type II (COPII) coat components and targeting and fusion factors in selective export from the endoplasmic reticulum (ER) and transport to the Golgi, we have developed three novel, stage-specific assays. Cargo selection can be measured using a "stage 1 cargo capture assay," in which ER microsomes are incubated in the presence of glutathione S-transferase (GST)-tagged Sar1 GTPase and purified Sec23/24 components to follow recruitment of biosynthetic cargo to prebudding complexes. This cargo recruitment assay can be followed by two sequential assays that measure separately the budding of COPII-coated vesicles from ER microsomes (stage 2) and, finally, delivery of cargo-containing vesicles to the Golgi (stage 3). We show how these assays provide a means to identify the snap receptor (SNARE) protein rBet1 as an essential component that is not required for vesicle formation, but is required for vesicle targeting and fusion during ER-to-Golgi transport. In general, these assays provide an approach to characterize the biochemical basis for the recruitment of a wide variety of biosynthetic cargo proteins to COPII vesicles and the role of different transport components in the early secretory pathway of mammalian cells.
Asunto(s)
Retículo Endoplásmico/metabolismo , Aparato de Golgi/metabolismo , Glicoproteínas de Membrana , Proteínas de la Membrana/metabolismo , Proteínas de Saccharomyces cerevisiae , Proteínas de Transporte Vesicular , Transporte Biológico , Proteínas Portadoras/metabolismo , Proteínas de Unión al GTP Monoméricas/metabolismo , Fosfoproteínas/metabolismo , Unión Proteica , Proteínas SNARE , Proteínas del Envoltorio Viral/metabolismoRESUMEN
How does the Golgi stack mediate transport of cargo from the endoplasmic reticulum (ER) to the cell surface? A possibility is that cargo-containing vesicles derived from the ER form early Golgi compartments that then mature by retrieval of processing enzymes from later Golgi compartments. Maturation continues at terminal Golgi compartments by retrieval of transport components from the endocytic pathway to promote sorting of cargo to multiple cellular destinations. Hence, retrograde movement may integrate exocytic and endocytic pathways in eukaryotic cells and coordinate membrane flow and cargo transport through the Golgi stack.
Asunto(s)
Endocitosis , Retículo Endoplásmico/metabolismo , Exocitosis , Aparato de Golgi/metabolismo , Proteínas/metabolismo , Animales , Transporte Biológico , Membrana Celular/metabolismo , Vesículas Cubiertas/metabolismo , Proteína Coatómero , Aparato de Golgi/enzimología , Aparato de Golgi/ultraestructura , Proteínas de la Membrana/metabolismoRESUMEN
The expression of a luciferase reporter gene under the control of the human glucose 6-phosphatase gene promoter was stimulated by both dexamethasone and dibutyryl cAMP in H4IIE hepatoma cells. A cis-active element located between nucleotides -161 and -152 in the glucose 6-phosphatase gene promoter was identified and found to be necessary for both basal reporter-gene expression and induction of expression by both dibutyryl cAMP and dexamethasone. Nucleotides -161 to -152 were functionally replaced by the consensus sequence for a cAMP response element. An antibody against the cAMP response element-binding protein caused a supershift in gel-electrophoretic-mobility-shift assays using an oligonucleotide probe representing the glucose 6-phosphatase gene promoter from nucleotides -161 to -152. These results strongly indicate that in H4IIE cells the glucose 6-phosphatase gene-promoter sequence from -161 to -152 is a cAMP response element which is important for the regulation of transcription of the glucose 6-phosphatase gene by both cAMP and glucocorticoids.
Asunto(s)
AMP Cíclico/farmacología , Dexametasona/farmacología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Glucosa-6-Fosfatasa/genética , Regiones Promotoras Genéticas , Transcripción Genética/efectos de los fármacos , Secuencia de Bases , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/patología , Secuencia de Consenso , AMP Cíclico/metabolismo , ADN , Glucosa-6-Fosfatasa/metabolismo , Humanos , Hidrólisis , Datos de Secuencia Molecular , Timidina Quinasa/genética , Células Tumorales CultivadasRESUMEN
The glucose-6-phosphatase system was investigated in fetal rat liver microsomal vesicles. Several observations indicate that the orientation of the catalytic subunit is different in the fetal liver in comparison with the adult form: (i) the phosphohydrolase activity was not latent using glucose-6-phosphate as substrate, and in the case of other phosphoesters it was less latent; (ii) the intravesicular accumulation of glucose upon glucose-6-phosphate hydrolysis was lower; (iii) the size of the intravesicular glucose-6-phosphate pool was independent of the glucose-6-phosphatase activities; (iv) antibody against the loop containing the proposed catalytic site of the enzyme inhibited the phosphohydrolase activity in fetal but not in adult rat liver microsomes. Glucose-6-phosphate, phosphate, and glucose uptake could be detected by both light scattering and/or rapid filtration method in fetal liver microsomes; however, the intravesicular glucose-6-phosphate and glucose accessible spaces were proportionally smaller than in adult rat liver microsomes. These data demonstrate that the components of the glucose-6-phosphatase system are already present, although to a lower extent, in fetal liver, but they are functionally uncoupled by the extravesicular orientation of the catalytic subunit.
Asunto(s)
Glucosa-6-Fosfatasa/metabolismo , Hígado/enzimología , Animales , Animales Recién Nacidos , Anticuerpos/inmunología , Dominio Catalítico , Glucosa/metabolismo , Glucosa-6-Fosfatasa/química , Glucosa-6-Fosfatasa/inmunología , Glucosa-6-Fosfato/metabolismo , Hígado/embriología , Hígado/crecimiento & desarrollo , Masculino , Microsomas Hepáticos/enzimología , Microsomas Hepáticos/metabolismo , Fosfatos/metabolismo , Monoéster Fosfórico Hidrolasas/metabolismo , Conformación Proteica , Ratas , Ratas Sprague-DawleyRESUMEN
Net sulfation of 4-methylumbelliferone in intact hepatocytes is regulated, in part, by substrate cycling between sulfotransferases (SULT) and arylsulfatases (ARS). Thus, ARS have the potential to influence rates of net sulfate conjugation of a variety of compounds in intact cells via interaction with SULT. Unlike ARSA and ARSB, which are lysosomal, steroid sulfate sulfatase (ARSC, also known as STS) is localized exclusively in the endoplasmic reticulum (ER). The present study was designed to assess the existence and extent of substrate cycling between steroids and their sulfate conjugates through ARSC and SULT, and also to initiate studies of the topology of the catalytic site of ARSC in the rat liver ER. Addition of rat liver microsomes to cytosol and 3'-phosphoadenosine 5'-phosphosulfate (PAPS) reduced rates of sulfation of dehydroepiandrosterone (DHEA) by SULT, and similarly hydrolysis of DHEA sulfate (DHEAS) was reduced when recombinant human hydroxysteroid SULT was added to rat liver microsomes in the presence of PAPS. There was no evidence for ARSC latency in the presence of detergent at either 4 or 37 degrees C, indicating that facilitated transport of steroid sulfates across the ER membrane may not be required for ARSC activity. The effect of proteases on ARSC activity in intact and disrupted microsomes was determined and compared with effects on components of the glucose-6-phosphatase system known to be localized on the lumenal and cytoplasmic surfaces of the ER. In contrast to the components of the glucose-6-phosphatase system, activity of ARSC in both intact and disrupted microsomes was substantially more resistant to protease inactivation. Our results indicate that substrate cycling of steroids and their sulfates does occur, and suggest that the active site of ARSC may be located within the ER membrane.
Asunto(s)
Arilsulfatasas/metabolismo , Arilsulfotransferasa/metabolismo , Citosol/enzimología , Microsomas Hepáticos/enzimología , Animales , Deshidroepiandrosterona/metabolismo , Sulfato de Deshidroepiandrosterona/metabolismo , Humanos , Hidrólisis , Cinética , Masculino , Fosfoadenosina Fosfosulfato/metabolismo , Proteínas/metabolismo , Ratas , Ratas Wistar , Esteril-Sulfatasa , Fracciones Subcelulares/enzimología , Sulfatos/metabolismo , TemperaturaRESUMEN
OBJECTIVE: To examine the trends in the proportion of annual live births that were male in Canada and to compare the trends with those in the United States. DESIGN: Analysis of census data. SETTING: Canada as a whole and 4 main regions (West, Ontario, Quebec and Atlantic). SUBJECTS: All live births from 1930 to 1990. OUTCOME MEASURES: Sex ratio (expressed as the proportion of total live births that were male [male proportion]) overall and by region. RESULTS: The male proportion in Canada decreased significantly after 1970 (p < 0.001); this represented a cumulative loss of 2.2 male births per 1000 live births from 1970 to 1990. Although a decrease was observed in all four regions studied, only that in the Atlantic region was significant (p < 0.001), representing a cumulative loss of 5.6 male births per 1000 live births from 1970 to 1990. A significant decrease in the male proportion was also observed in the United States from 1970 to 1990 (p < 0.001), although to a lesser degree than that observed in Canada, and represented a cumulative loss of 1.0 male births per 1000 live births. CONCLUSIONS: The decreased sex ratio in Canada adds to the growing debate over changes in biological markers and their potential causes. In addition, the study illustrates the potential use of the sex ratio as a widely available, unambiguous measure of the reproductive health of large populations.
Asunto(s)
Tasa de Natalidad , Razón de Masculinidad , Canadá/epidemiología , Femenino , Humanos , Modelos Logísticos , Masculino , Distribución por Sexo , Estados Unidos/epidemiologíaRESUMEN
We have cloned and sequenced the first 1.2 kb of the 5' region of the human glucose-6-phosphatase gene. Transfection of H4IIE hepatoma cells with the 1.2 kb fragment fused to a luciferase reporter gene demonstrated both basal and hormone responsive luciferase activity. Dexamethasone increased and insulin decreased luciferase activity. Insulin and dibutyryl cyclic AMP both significantly decreased activity in the presence of dexamethasone.
Asunto(s)
Bucladesina/farmacología , Dexametasona/farmacología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Glucosa-6-Fosfatasa/genética , Insulina/farmacología , Animales , Secuencia de Bases , Clonación Molecular , Genes Reporteros , Humanos , Neoplasias Hepáticas Experimentales , Datos de Secuencia Molecular , Regiones Promotoras Genéticas/genética , Ratas , Transcripción Genética , Transfección/genética , Células Tumorales CultivadasRESUMEN
Recently, using immunohistochemical methods, we surprisingly found that endoplasmic reticulum glucose-6-phosphatase is present in human embryonic and fetal red blood cells (RBCs) but not in adult RBCs. The fact that an endoplasmic reticulum enzyme, whose major site of expression in adults is the liver, is present in human embryonic and fetal RBCs, particularly nucleated cells, indicated that it would be sensible to determine whether these cells also contain other endoplasmic reticulum enzyme systems normally found in adult liver. Therefore, we have studied the expression of other endoplasmic reticulum proteins and found that human embryonic and fetal RBC precursors contain other protein components of the glucose-6-phosphatase system, ie, the phosphate and glucose transport proteins as well as other enzymes (eg, uridine diphosphate-glucuronosyltransferases, cytochrome P450 isozymes, nicotinamide adenine dinucleotide phosphate cytochrome P450 oxidoreductase, and prostaglandin H synthase). In addition, we also found the predominantly cytosolic markers 15-hydroxyprostaglandin dehydrogenase, prostaglandins PGE2 and 13,14-dihydro-15-keto-PGE2. The expression of key enzymes that control glucose production, detoxification of endobiotics and xenobiotics, and the regulation of prostaglandin levels in embryonic and early fetal RBCs means that these cells may have an important role in protecting the developing conceptus before it establishes an efficient circulation and before all tissues fully express their normal complement of these enzymes.
Asunto(s)
Retículo Endoplásmico/metabolismo , Inducción Enzimática , Enzimas/sangre , Eritrocitos/enzimología , Sangre Fetal/citología , Proteínas Fetales/biosíntesis , Regulación del Desarrollo de la Expresión Génica , Sistema Hematopoyético/embriología , Adulto , Secuencia de Bases , Metabolismo Energético/genética , Enzimas/biosíntesis , Enzimas/genética , Eritrocitos/fisiología , Eritropoyesis , Sangre Fetal/enzimología , Sangre Fetal/fisiología , Proteínas Fetales/genética , Sistema Hematopoyético/enzimología , Sistema Hematopoyético/crecimiento & desarrollo , Humanos , Inactivación Metabólica/genética , Riñón/embriología , Riñón/enzimología , Riñón/crecimiento & desarrollo , Hígado/embriología , Hígado/enzimología , Hígado/crecimiento & desarrollo , Microsomas Hepáticos/enzimología , Datos de Secuencia Molecular , Prostaglandinas/biosíntesis , Bazo/embriología , Bazo/enzimología , Bazo/crecimiento & desarrolloAsunto(s)
Glucosa-6-Fosfatasa/metabolismo , Hígado/enzimología , Animales , Línea Celular , Difosfatos/metabolismo , Fructosafosfatos/metabolismo , Glucosa-6-Fosfato , Glucofosfatos/metabolismo , Neoplasias Hepáticas Experimentales/enzimología , Ratas , Especificidad por Sustrato , Células Tumorales CultivadasRESUMEN
Hepatic glucose-6-phosphatase (G-6-Pase) catalyses the terminal step of hepatic glucose production and it plays a key role in the maintenance of blood glucose homeostasis. Hepatic G-6-Pase is an integral resident endoplasmic reticulum (ER) protein and it is part of a multicomponent system. Its active site is situated inside the lumen of the ER and transport proteins are needed to allow its substrates, glucose-6-phosphate (G-6-P) (and pyrophosphate), and its products, phosphate and glucose to cross the ER membrane. In addition, a calcium-binding protein is also associated with the G-6-Pase enzyme. Recent immunological studies have shown that G-6-Pase (which has conventionally been thought to be present only in the gluconeogenic organs) is present in minor cell types in a variety of human tissues and that its distribution changes dramatically during human development. In all the tissues, enzymatic analysis, direct transport assays and/or immunological detection of the ER glucose and phosphate transport proteins have been used to demonstrate the presence and activity of the whole G-6-Pase system. The G-6-Pase protein is very hydrophobic and has proved difficult to purify to homogeneity. Four proteins of the system have now been isolated and polyclonal antibodies have been raised against them; two have also been cloned. The available sequences, together with topological studies, have given some information about both the topology of the proteins in the ER and the probable mechanisms by which the proteins are retained in the ER.